U.S. Stock News

NYSE:CHE
NYSE:CHEHealthcare

Does Chemed (CHE)’s 221st Straight Dividend Hike Reveal Its True Capital Allocation Priorities?

Chemed Corporation recently declared a quarterly cash dividend of US$0.70 per share, paid on September 3, 2026, to shareholders of record as of August 17, 2026, representing a 10‑cent increase over the June payout and marking its 221st consecutive quarterly dividend in 55 years as a public company. This long-running pattern of uninterrupted quarterly dividends, alongside a recent 17% increase, underlines how consistently Chemed has prioritized direct cash returns to shareholders. With this...
NYSE:NKE
NYSE:NKELuxury

How Nike’s Weak Results and Leadership Shifts At NIKE (NKE) Have Changed Its Investment Story

In recent weeks, Nike has faced pressure from weak quarterly results, cautious consumer demand, analyst downgrades, and leadership changes, including the appointment of a new chief financial officer and the pending resignation of its chief accounting officer. At the same time, the company is leaning into community-focused initiatives such as The Crenshaw Rec by Foot Locker, developed with Nike, Jordan Brand, and Converse to deepen cultural relevance and brand engagement. These developments...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Capital Clean Energy Carriers (CCEC) Expands Its LNG Fleet, Is The Valuation Upside Already Priced In?

Capital Clean Energy Carriers (CCEC) is back on investor radars after updating progress on its US$20 million share repurchase program and taking delivery of its 15th latest generation LNG carrier, Alcaios I. See our latest analysis for Capital Clean Energy Carriers. Recent updates from Capital Clean Energy Carriers on its US$20 million buyback and growing LNG fleet come against a backdrop of steady price momentum, with the share price delivering a 10.49% year to date return and a 5 year total...
NasdaqGS:SANA
NasdaqGS:SANABiotechs

Can Sana Biotechnology (SANA) Justify Its Valuation On Narrower Losses?

Why Sana Biotechnology’s Latest Earnings Matter For Investors Sana Biotechnology (SANA) recently reported second quarter and half year 2026 results, showing narrower net losses and lower basic loss per share compared with the same periods a year earlier. The company recorded a second quarter net loss of US$63.64 million and basic loss per share from continuing operations of US$0.22. For the six month period, net loss was US$110.85 million with basic loss per share of US$0.39. See our latest...
NYSE:AEM
NYSE:AEMMetals and Mining

Will Rising AISC and Mixed Analyst Signals Change Agnico Eagle Mines' (AEM) Investment Narrative?

Recently, analysts highlighted that Agnico Eagle Mines is expected to face higher all-in sustaining costs as production expenses, royalties and sustaining capital rise, pressuring profitability relative to earlier expectations. At the same time, a contrast has emerged between bullish brokerage recommendations and a more cautious Zacks Rank based on earnings estimate revisions, underscoring differing views on Agnico Eagle’s near-term outlook. Next, we’ll examine how these expectations of...
NasdaqCM:FUFU
NasdaqCM:FUFUSoftware

BitFuFu (FUFU) Stock Faces Cash Strain Despite Leaner Mining Economics

BitFuFu stock closed flat at US$1.29 after Q2, which suggests the market has not made up its mind. The headline is a tug of war between a reported net loss of US$20.6 million and an operating picture that looks far less bleak once fair value swings on Bitcoin are stripped out. For a Bitcoin miner, power cost and hashrate efficiency matter more than headline revenue. BitFuFu leaned into that by keeping fleet efficiency competitive and driving electricity at its Oklahoma site to about US$0.03...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

Zenas BioPharma (ZBIO) Looks Pricey Following Weak Q2 Results And Leadership Changes

Zenas BioPharma (ZBIO) is back in focus after second quarter 2026 results showed revenue of US$1 million alongside a net loss of US$111.46 million, paired with several senior leadership changes. See our latest analysis for Zenas BioPharma. At a share price of US$31.91, Zenas BioPharma has seen a 90 day share price return of 63.14%, while the year to date share price return is down 7.51% and the 1 year total shareholder return is 101.32%. This suggests recent momentum has picked up even as the...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp (NTAP) Stock May Be 3% Overvalued Following JetStream Acquisition

After a strong multi year run, NetApp now trades at levels where its share price and the latest intrinsic value estimate are broadly in line, even as its broader valuation checks still lean expensive. NetApp has returned 184.0% over the past 5 years, which puts recent gains into a longer term context that investors need to factor into any valuation view. The acquisition of JetStream Software may support expectations for future data protection and cloud related cash flows. However,...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Camtek (CAMT) Posted Record Q2 Revenue, Is The AI Upside Already Priced In?

Camtek guidance and Q2 results put recent stock move in focus Camtek (NasdaqGM:CAMT) has drawn fresh attention after record second quarter revenue tied to Advanced Packaging for AI uses, rapid order intake above US$600 million year to date, and upbeat third quarter guidance. See our latest analysis for Camtek. Camtek's recent Q2 update and strong third quarter revenue guidance appear to have fed into building momentum, with a 1‑month share price return of 17.55% and a year to date share price...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Is Duolingo (DUOL) Still Undervalued As It Buys Animade After Strong Q2 Earnings?

Duolingo (DUOL) is back in focus after acquiring London based animation studio Animade. The move is aimed at strengthening user engagement and product experience following its recent second quarter 2026 earnings update. See our latest analysis for Duolingo. The recent Animade acquisition and Duolingo’s August earnings and guidance updates have come alongside a 90 day share price return of 30.72%, while the year to date share price is down 20.87% and the 1 year total shareholder return is down...
NYSE:AFL
NYSE:AFLInsurance

Aflac (AFL), What Is Behind The Fresh Attention Around The Insurer?

Why Aflac Stock Is In Focus After Q2 Earnings And Capital Returns Update Aflac (AFL) is drawing fresh attention after reporting second quarter 2026 results, affirming a $0.61 third quarter dividend, and updating investors on progress under its long running share repurchase program. See our latest analysis for Aflac. Aflac's share price has a 90 day share price return of 3.85% and a year to date share price return of 10.42%. The 5 year total shareholder return of 139.16% points to momentum...
NYSE:IBM
NYSE:IBMIT

Will IBM’s US$240 Million OpenAI and Together AI Bet Change International Business Machines' (IBM) Narrative?

International Business Machines Corporation recently announced a multi-year US$240 million collaboration with Together AI to deploy a large Nvidia HGX B300 inference cluster on IBM Cloud by early 2027, alongside an expanded partnership with OpenAI to embed frontier models such as GPT-5.6, Codex, and ChatGPT Work into IBM Consulting Advantage and cybersecurity offerings. By pairing OpenAI’s frontier AI models with IBM’s consulting, cloud, and autonomous security platforms, IBM is positioning...
NYSE:NOC
NYSE:NOCAerospace & Defense

Northrop Grumman (NOC) Won A Marine Corps Contract For Unmanned Aircraft Development

Northrop Grumman (NYSE:NOC) and Kratos Defense & Security Solutions received a U.S. Marine Corps contract to develop the Missionized Valkyrie Air Vehicle for the MUX TACAIR program. The Missionized Valkyrie will use Northrop Grumman’s mission kit and Open Architecture Autonomy Software for unmanned tactical aviation. The award expands Northrop Grumman’s role in unmanned systems for the Marine Air-Ground Task Force. Consider using this news as a starting point to review other defense and...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

Can CDW (CDW) Justify Its Valuation As New Results And Dividend Refresh The Story?

CDW (CDW) has drawn fresh investor attention after reporting second quarter 2026 results, including sales of US$6,572.2m and net income of US$274.4m, along with a declared quarterly dividend of US$0.630 per share. See our latest analysis for CDW. At a share price of US$134.97, CDW has recently seen a 90 day share price return of 27.08%, while the 1 year total shareholder return declined 17.90%. This suggests that recent momentum contrasts with weaker longer term outcomes. If CDW’s recent move...
NYSE:AD
NYSE:ADWireless Telecom

Array Digital Infrastructure (AD) Stock May Still Trade At A Discount On Earnings

Array Digital Infrastructure stock has delivered a 141.6% total return over the past 5 years, yet current checks on its valuation paint a more balanced picture rather than a clear bargain or an obvious overpricing. A 141.6% return over 5 years suggests Array Digital Infrastructure has already rewarded long term holders, which raises the bar for future returns from today's price. The key support for the valuation is whether the business can keep converting growth into durable cash flows. Any...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital (WDC) Gains On New US Curbs On Chinese Memory Chips

Western Digital (NasdaqGS:WDC) shares moved higher after the US government moved to restrict domestic tech firms from buying conventional memory chips from Chinese suppliers. The new policy is aimed at reducing reliance on Chinese memory producers and is seen as supportive for US-based memory and storage companies. Memory and storage stocks broadly rallied on the announcement, with investors focusing on potential long-term supply and pricing advantages for US firms. The move highlights the...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

How Trimble’s Impairment-Driven Loss, Raised Guidance, and Buybacks Will Impact Trimble (TRMB) Investors

In August 2026, Trimble Inc. reported second-quarter results showing revenue of US$972.0 million and a goodwill impairment of US$562.0 million, which contributed to a GAAP net loss of US$471.7 million and basic and diluted loss per share of US$2.02. At the same time, Trimble raised its full-year 2026 guidance, highlighted record annualized recurring revenue of US$2.51 billion, and authorized up to US$1.00 billion in share repurchases, signaling confidence in its subscription-focused,...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

COMPASS Pathways (CMPS) Following VA Trial News The Valuation Narrative Is Back In Focus

COMPASS Pathways (NasdaqGS:CMPS) drew fresh attention after announcing a multi-site randomized controlled trial with the U.S. Department of Veterans Affairs to evaluate its COMP360 psilocybin therapy in veterans with treatment resistant depression and PTSD. See our latest analysis for COMPASS Pathways. The VA trial news lands after a sharp run in COMPASS Pathways' share price, with a 30 day share price return of 12.63% and a year to date share price return of 112.37%. The 1 year total...
NasdaqGS:CHCO
NasdaqGS:CHCOBanks

City Holding (CHCO), Why Is The Stock Drawing Fresh Attention?

City Holding (CHCO) has drawn investor attention after recent share price moves, with the stock last closing at $146.22. This follows a month of gains and a stronger performance over the past three months. See our latest analysis for City Holding. Over a longer stretch, City Holding has seen a 30 day share price return of 7.70% and a 90 day share price return of 18.03%, while its 5 year total shareholder return of 115.28% shows how gains have compounded over time. If you are looking beyond...
NYSE:LNG
NYSE:LNGOil and Gas

How Cheniere’s Upgraded 2026 Outlook and Aggressive Buybacks Will Impact Cheniere Energy (LNG) Investors

Cheniere Energy, Inc. recently reported second-quarter 2026 results showing revenue of US$5,732 million and net income of US$3,068 million, while also lifting full-year 2026 net income guidance to US$1.60–2.00 billion and nudging up its LNG production forecast to 53–54 million tonnes. The company also disclosed that it has repurchased a cumulative 56,641,068 shares, or 24.1% of its share count, since 2019 for about US$9.27 billion, underscoring an ongoing commitment to returning capital...
NYSE:WT
NYSE:WTCapital Markets

WisdomTree (WT) Stock Looks Fully Priced After Strong Growth

WisdomTree stock has delivered very strong returns over the past five years, yet the current valuation checks suggest the shares are pricing in a lot of good news already rather than offering an obvious bargain. WisdomTree has returned 291.6% over the past five years, which puts extra focus on whether recent gains are now running ahead of fundamentals. Robust asset inflows and growth in assets under management can support higher earnings expectations, while any slowdown in demand for key...
NasdaqGM:JANX
NasdaqGM:JANXBiotechs

Janux Therapeutics (JANX) Narrows Quarterly Losses, Is The Premium Valuation Too Rich?

Janux Therapeutics (JANX) stock is in focus after the company reported second quarter 2026 results, with net loss narrowing to US$21.97 million and basic loss per share from continuing operations at US$0.35. See our latest analysis for Janux Therapeutics. The latest earnings update appears to be feeding into a shift in how investors view Janux Therapeutics, with the share price at US$16.26 and a 90 day share price return of 17.74%, alongside a 3 year total shareholder return of 43.77% that...
NYSE:DAO
NYSE:DAOConsumer Services

Youdao (DAO) Could Be 206% Overvalued After Its Run To $17.01

Youdao (NYSE:DAO) has drawn fresh attention after its recent share price move, with the stock closing at US$17.01 on 18 August 2026. Investors are weighing this level against its recent performance and fundamentals. See our latest analysis for Youdao. The recent move to US$17.01 follows a sharp 1 day share price return of 4.42%, building on a 30 day share price return of 16.91% and a 90 day share price return of 37.18%. Over a longer horizon, momentum is also reflected in Youdao’s 1 year...
NYSE:KFY
NYSE:KFYProfessional Services

Does Korn Ferry’s Planned 2027 Note Redemption Reshape the Bull Case For KFY’s Capital Structure?

Korn Ferry has issued a conditional notice to redeem its 4.625% Senior Notes due 2027, planning to retire the full US$400,000,000 principal plus accrued interest in cash on August 18, 2026, subject to completing new debt financing. This move highlights an active reshaping of Korn Ferry’s capital structure, as the company weighs refinancing options while managing upcoming debt obligations. We’ll now examine how this planned redemption and refinancing of US$400,000,000 in notes could...